There is currently no moderator assigned to this section of Vetbook. The contents of this page have therefore not been independently verified and are not available for editing. Parties wishing to contribute to the moderation and development of Vetbook are invited to contact us at


From Dog
Jump to: navigation, search

Procarbazine is an alkylating agent used for the treatment canine lymphoma. Procarbazine is T cell-specific and crosses the blood-brain barrier[1].

It also has immunosuppressive effects.

Recommended dose is 25 - 50 mg/m2 per day on a 21 day cycle.

Procarbazine can sometimes cause neurotoxicity, but myelosuppression (thrombocytopenia, leukopenia) seems to be the major limiting factor.


  1. Coates JR et al (2007) Procarbazine as adjunctive therapy for treatment of dogs with presumptive antemortem diagnosis of granulomatous meningoencephalomyelitis: 21 cases (1998-2004). J Vet Intern Med 21(1):100-106